Sequence analysis of antimicrobial peptides by tandem mass spectrometry

Area of Science:

• Microbiology and Biochemistry
• Drug Discovery and Development

Background:

• Rising antibiotic resistance and emerging infectious diseases necessitate novel therapeutic strategies.
• Antimicrobial peptides (AMPs) are a promising class of compounds with broad-spectrum antibacterial activity.
• Conventional antibiotics face challenges due to increasing bacterial resistance.

Purpose of the Study:

• To describe laboratory protocols for identifying and sequencing antimicrobial peptides (AMPs).
• To focus on mass spectrometry-based approaches for de novo sequence analysis of AMPs.
• To aid in the discovery of new antibacterial agents against resistant pathogens.

Main Methods:

• Multidimensional purification strategies are essential due to low natural concentrations of AMPs in biological fluids.
• Highly sensitive analytical techniques, including mass spectrometry, are required for peptide sequencing.
• De novo sequence analysis using mass spectrometry is routinely employed.

Main Results:

• The described protocols enable the identification of peptides with antimicrobial activities.
• Mass spectrometry provides sensitive and accurate sequencing of low-abundance peptides.
• De novo sequencing allows for the determination of unknown peptide sequences.

Conclusions:

• Effective laboratory protocols are crucial for isolating and characterizing antimicrobial peptides.
• Mass spectrometry-based de novo sequencing is a powerful tool for discovering novel AMPs.
• This research contributes to the ongoing search for new treatments against antibiotic-resistant bacteria.